Impact of the COVID-19 Pandemic on Metabolic and Bariatric Surgery Utilization and Safety in the United States.
Impact of the COVID-19 Pandemic on Metabolic and Bariatric Surgery Utilization and Safety in the United States.
复制标题
DOI：
10.1007/s11695-022-06077-x
复制
发表时间：
2022-07
期刊：
影响因子：
2.9
通讯作者：
de la Cruz-Munoz, Nestor
中科院分区：
文献类型：
--
作者：
Messiah, Sarah E.;Xie, Luyu;Mathew, Matthew Sunil;Marroquin, Elisa Marroquin;Almandoz, Jaime P.;Qureshi, Faisal G.;Schneider, Benjamin E.;de la Cruz-Munoz, Nestor
代谢和减肥手术（MBS）是严重肥胖症的安全有效的治疗选择。2019冠状病毒病大流行期间与2015 - 2019年相比，MBS在美国青少年和成年人群中以及按种族划分的使用情况以及健康和安全结果在很大程度上尚不清楚。使用2015 - 2020年代谢和减肥手术认证和质量改进计划（MBSAQIP）纵向（30天）队列数据比较青少年和成人（N = 1，134，522）术后结局，并计算流行前（2015 - 2019）与流行（2020）的MBS使用率。Cochran-Armitage趋势测试比较了2015年至2020年期间MBS的利用率和安全性结果。Logistic回归分析比较了流感大流行前与流感大流行前的主要特征的再入院率和MBS完成率。从2019年到2020年，年轻人的MBS使用率增加了8.1%（从970例增加到1140例），成年人的MBS使用率下降了10.2%（从205，232例减少到167，384例）。在大流行期间，被确定为其他/多种族的年轻人的MBS增加了18.5%（P趋势<0.001）。在美国青年中，再手术和再干预的数量在6年的时间范围内显著下降（P趋势<0.001）。在美国成年人中，MBS后30天死亡率、再手术率、再入院率和再干预率均随时间显著下降（P趋势<0.001），而脓毒性休克和脓毒症从大流行前到大流行第一年增加（P趋势<0.001）。与二零一九年（或过往年度）相比，于COVID-19疫情爆发首年，美国青年MBS使用率上升，但成年MBS使用率下降。安全性结果与大流行前的结果相当。
Metabolic and bariatric surgery (MBS) is a safe and effective treatment option for severe obesity. The utilization and health and safety outcomes of MBS in the United States (US) during the COVID-19 pandemic versus 2015–2019 among adolescent and adult populations and by ethnic group is largely unknown. The 2015–2020 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) longitudinal (30-day) cohort data was used to compare adolescent and adult (N = 1,134,522) post-operative outcomes and to calculate MBS utilization pre-pandemic (2015–2019) versus pandemic (2020). Cochran-Armitage trend tests compared MBS utilization and safety outcomes over time from 2015 to 2020. Logistic regression analysis compared the odds of hospital readmission and MBS completion pre-pandemic versus pandemic by key characteristics. MBS utilization increased by 8.1% among youth (from 970 to 1140 procedures) and decreased by 10.2% among adults (from 205,232 to 167,384) from 2019 to 2020, respectively. MBS increased by 18.5% during the pandemic for youth who identified as other/multiracial (P trend < 0.001). Among US youth, the number of reoperations and reinterventions significantly decreased over the 6-year time frame (P trend < .001). Among US adults, 30-day post MBS mortality, reoperations, readmissions, and reinterventions all showed a significant decrease over time (P trend < .001) while septic shock and sepsis increased from pre-pandemic to the first year of the pandemic (P trend < 0.001). In comparison to 2019 (or to previous years), US MBS utilization increased for youth but decreased for adults during the first year of the COVID-19 pandemic. Safety outcomes were comparable to those of the pre-pandemic years.
登录
查看更多内容
影响因子：
9
作者：
通讯作者：
--
影响因子：
2.7
作者：
He, Ming;Xian, Yin;Ren, Yixing
通讯作者：
Ren, Yixing
影响因子：
3.1
作者：
English, Wayne J.;DeMaria, Eric J.;Morton, John M.
通讯作者：
Morton, John M.
DOI：
10.1016/s2213-8587(21)00089-9
发表时间：
2021-06
期刊：
The lancet. Diabetes & endocrinology
影响因子：
--
作者：
Gao M;Piernas C;Astbury NM;Hippisley-Cox J;O'Rahilly S;Aveyard P;Jebb SA
通讯作者：
Jebb SA
影响因子：
5.9
作者：
Chang TH;Chen YC;Chen WY;Chen CY;Hsu WY;Chou Y;Chang YH
通讯作者：
Chang YH